West Pharmaceutical Services (WST) Gross Profit (2009 - 2026)
West Pharmaceutical Services (WST) posted Gross Profit of $329.2 million for Q2 2026, up 11.07% sequentially from $296.4 million in Q1 2026, and up 20.19% YoY from $273.9 million in Q2 2025.
West Pharmaceutical Services (WST) Gross Profit (2009 - 2026) Analysis & Trends
West Pharmaceutical Services has reported Gross Profit for 18 years, with the latest figure at $329.2 million in Q2 2026.
- Quarterly Gross Profit rose 20.19% year-over-year to $329.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.2 billion (up 17.21% YoY) and the FY2025 annual result came in at $1.1 billion, up 10.57% from the prior year.
- Gross Profit advanced to $329.2 million in Q2 2026 per WST's latest filing, from $296.4 million in the prior quarter.
- Over five years, Gross Profit peaked at $329.2 million in Q2 2026 and troughed at $230.0 million in Q2 2024.
- A 5-year average of $277.4 million and a median of $276.0 million in 2023 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2024 and 2026: Gross Profit fell 21.07% in 2024, then rose 27.81% in 2026.
- Over 5 years, Gross Profit stood at $262.1 million in 2022, then grew by 6.14% to $278.2 million in 2023, then fell by 1.65% to $273.6 million in 2024, then climbed by 11.07% to $303.9 million in 2025, then rose by 8.33% to $329.2 million in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $329.2 million, $296.4 million, and $303.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|